Eaux De Royan Stock Quote MLEDR - Stock Price, News, Charts, Message Board, Trades

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
Europe
EU
Eaux De Royan (MLEDR) Quote

Eaux De Royan (MLEDR)

50.00

2.60

(5.49%)

Closed November 21 11:30AM

Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Current Price

50.00

Bid

42.00

Ask

60.00

Volume

202

50.00 Day's Range 51.00

46.40 52 Week Range 91.00

Market Cap

Previous Close

47.40

Open

51.00

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

32

Shares Outstanding

179,200

Dividend Yield

3.02%

PE Ratio

33.19

Earnings Per Share (EPS)

1.51

Revenue

12.61M

Net Profit

270k

Sector

Water Supply

Industry

Water Supply

Website

www.cer-eau.fr

Headquarters

La Rochelle, Charente-maritime, Fra

Founded

-

Eaux De Royan is listed in the Water Supply sector of the Euronext with ticker MLEDR. The last closing price for Eaux De Royan was 47.40 €. Over the last year, Eaux De Royan shares have traded in a share price range of 46.40 € to 91.00 €.

Eaux De Royan currently has 179,200 shares outstanding. The market capitalization of Eaux De Royan is 8.49 € million. Eaux De Royan has a price to earnings ratio (PE ratio) of 33.19.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	2.2	4.60251046025	47.8	51	47.4	5	47.4	DE
4	-8.5	-14.5299145299	58.5	58.5	46.4	30	48.15090312	DE
12	-12	-19.3548387097	62	62	46.4	32	56.14376289	DE
26	-37	-42.5287356322	87	87	46.4	23	59.61953566	DE
52	-34	-40.4761904762	84	91	46.4	17	67.85077233	DE
156	-55	-52.380952381	105	105	46.4	21	83.71966846	DE
260	-91	-64.5390070922	141	146	46.4	20	94.18781165	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BIDSGascogne DS	0.004 € (122.22%)	80.49k
MLFDVFranck Deville	0.41 € (51.85%)	10
SCHDScheerders van Kerchoves Verenigde Fabrieken	388.00 € (20.50%)	22
MLIMLImalliance	0.36 € (20.00%)	640
ALCBICrypto Blockchain Industries	0.274 € (19.13%)	1.09M
ATODSAtos SE	0.001 € (-75.61%)	34.97M
EBUSEbusco Holding NV	0.88 € (-28.22%)	3.41M
ALDOLDolfines	2.30 € (-19.58%)	4.03k
CNVCnova NV	0.80 € (-19.19%)	800
ATOAtos SE	0.1561 € (-18.91%)	7.82M
ALNEVNeovacs	0.0002 € (0.00%)	52.1M
BCPBanco Comercial Portugues SA	0.4468 € (1.59%)	39.08M
ATODSAtos SE	0.001 € (-75.61%)	34.97M
ALTDTonner Drones	0.01 € (8.70%)	14.48M
ALVERVergnet	0.0042 € (-12.50%)	12.7M

manibiotech

manibiotech 4 minutes ago

However the data of current trial submitted for approval is not "in vitro"

payupdeadbeat

payupdeadbeat 4 minutes ago

It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.

Craig305

Craig305 5 minutes ago

This is the highest day volume since June 2022.

Serpico2005

Serpico2005 5 minutes ago

HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer.

delerious1

delerious1 5 minutes ago

Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the

ExtremelyBullishZig

ExtremelyBullishZig 5 minutes ago

No...all biotechs are up based on gene editing company success it move the index

richme

richme 5 minutes ago

Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).

Quintessence

Quintessence 5 minutes ago

PDYNW - Nice move today! I will consider buying dips.

JRoon71

JRoon71 5 minutes ago

TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to

dennisdave

dennisdave 6 minutes ago

BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.

attilathehunt

attilathehunt 6 minutes ago

1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0

bgATL

bgATL 6 minutes ago

Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it

Pic 6 minutes ago

I wonder if .0011 is a good entry? Fishing time. 🎣

konshe

konshe 7 minutes ago

Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.

al44

al44 7 minutes ago

The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner

When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.

Real McCoy

Real McCoy 7 minutes ago

I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.

KRISGO

KRISGO 7 minutes ago

Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?

PennyMillions852

PennyMillions852 7 minutes ago

BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!

Hitman970

Hitman970 7 minutes ago

Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.

CrashOverride

CrashOverride 7 minutes ago

If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.

biotechinvestor1

biotechinvestor1 7 minutes ago

From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”

BamaBreeze

BamaBreeze 7 minutes ago

Can you bring in the update your referencing(please).

redspinelpinktopaz

redspinelpinktopaz 7 minutes ago

No. It seems all right to me.

glenn1919

glenn1919 7 minutes ago

TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

WinstonCup

WinstonCup 8 minutes ago

Sometimes you make no sense.

Delayed Upgrade Clock